0000876661-17-000741.txt : 20171208
0000876661-17-000741.hdr.sgml : 20171208
20171208151434
ACCESSION NUMBER: 0000876661-17-000741
CONFORMED SUBMISSION TYPE: 25-NSE
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20171208
DATE AS OF CHANGE: 20171208
EFFECTIVENESS DATE: 20171208
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: PharMerica CORP
CENTRAL INDEX KEY: 0001388195
STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
IRS NUMBER: 870792558
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33380
FILM NUMBER: 171246984
BUSINESS ADDRESS:
STREET 1: 1901 CAMPUS PLACE
CITY: LOUISVILLE
STATE: KY
ZIP: 40299
BUSINESS PHONE: 502.627.7000
MAIL ADDRESS:
STREET 1: 1901 CAMPUS PLACE
CITY: LOUISVILLE
STATE: KY
ZIP: 40299
FORMER COMPANY:
FORMER CONFORMED NAME: SAFARI HOLDING CORP
DATE OF NAME CHANGE: 20070130
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NEW YORK STOCK EXCHANGE LLC
CENTRAL INDEX KEY: 0000876661
IRS NUMBER: 000000000
STATE OF INCORPORATION: NY
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
BUSINESS PHONE: 212-656-2060
MAIL ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
FORMER COMPANY:
FORMER CONFORMED NAME: NEW YORK STOCK EXCHANGE INC
DATE OF NAME CHANGE: 19910628
25-NSE
1
primary_doc.xml
X0203
0000876661
NEW YORK STOCK EXCHANGE LLC
1388195
PharMerica CORP
001-33380
1901 Campus Place
Louisville
KY
KENTUCKY
40299
(502) 627-7000
Common Stock
17 CFR 240.12d2-2(a)(3)
Victoria Paper
Senior Analyst
2017-12-08
EX-99.25
2
ruleprovisionnotice.htm
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES
The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on December 19, 2017, pursuant to the provisions of Rule 12d2-2 (a).
[ X ] 17 CFR 240.12d2-2(a)(3) That on December 7, 2017 the instruments representing the securities comprising the entire class of this security came to evidence, by operation of law or otherwise, other securities in substitution therefore and represent no other right except, if such be the fact, the right to receive an immediate cash payment.
The merger between PharMerica Corporation and Phoenix Merger Sub Inc., a wholly owned subsidiary of Phoenix Parent Holdings Inc., an entity which is an affiliate of investment funds affiliated with Kohlberg Kravis Roberts & Co. L.P. became effective on December 7, 2017. Each share of Common Stock of PharMerica Corporation was converted into $29.25 in cash per share.
The Exchange also notifies the Securities and Exchange Commission that as a result of the above indicated conditions this security was suspended from trading on December 8, 2017.